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Introduction: The extracellular signals regulating mammary epithelial cell growth are of relevance to
understanding the pathophysiology of mammary epithelia, yet they remain poorly characterized. In this study, we
applied an unbiased approach to understanding the functional role of signalling molecules in several models of
normal physiological growth and translated these results to the biological understanding of breast cancer subtypes.
Methods: We developed and utilized a cytogenetically normal clonal line of hTERT immortalized human mammary
epithelial cells in a fibroblast-enhanced co-culture assay to conduct a genome-wide small interfering RNA (siRNA)
screen for evaluation of the functional effect of silencing each gene. Our selected endpoint was inhibition of
growth. In rigorous postscreen validation processes, including quantitative RT-PCR, to ensure on-target silencing,
deconvolution of pooled siRNAs and independent confirmation of effects with lentiviral short-hairpin RNA constructs, we
identified a subset of genes required for mammary epithelial cell growth. Using three-dimensional Matrigel growth and
differentiation assays and primary human mammary epithelial cell colony assays, we confirmed that these growth effects
were not limited to the 184-hTERT cell line. We utilized the METABRIC dataset of 1,998 breast cancer patients to evaluate
both the differential expression of these genes across breast cancer subtypes and their prognostic significance.
Results: We identified 47 genes that are critically important for fibroblast-enhanced mammary epithelial cell growth.
This group was enriched for several axonal guidance molecules and G protein–coupled receptors, as well as for the
endothelin receptor PROCR. The majority of genes (43 of 47) identified in two dimensions were also required for
three-dimensional growth, with HSD17B2, SNN and PROCR showing greater than tenfold reductions in acinar formation.
Several genes, including PROCR and the neuronal pathfinding molecules EFNA4 and NTN1, were also required for proper
differentiation and polarization in three-dimensional cultures. The 47 genes identified showed a significant nonrandom
enrichment for differential expression among 10 molecular subtypes of breast cancer sampled from 1,998 patients.
CD79A, SERPINH1, KCNJ5 and TMEM14C exhibited breast cancer subtype–independent overall survival differences.
Conclusion: Diverse transmembrane signals are required for mammary epithelial cell growth in two-dimensional and
three-dimensional conditions. Strikingly, we define novel roles for axonal pathfinding receptors and ligands and the
endothelin receptor in both growth and differentiation.* Correspondence: saparicio@bccrc.ca
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The identification of distinct cell types that appear to be
hierarchically organized in the mammary epithelial
glands of healthy women is now well established [1].
This hierarchy is defined largely by two prospectively
separable subsets of cells that generate colonies containing
only one or both lineages (myoepithelial and/or luminal)
of cells that make up the bulk of the normal mammary
gland structure. The bipotent, clonogenic, progenitor-
enriched basal cell fraction also contains putative human
mammary stem cells identified in xenotransplantation
assays [2,3]. The ability of human mammary cells to
be propagated both in vitro and in vivo at limited
densities is known to be markedly enhanced by the
presence of fibroblast ‘feeders’ [2,4,5]. These and many
other studies have shown that fibroblast interactions are
important to the growth of mammary epithelial cells
[6-12]. However, a comprehensive characterization of the
mechanisms by which fibroblasts regulate the growth and
functional organization of normal mammary epithelial
cells has been lacking.
Genome-wide RNA interference (RNAi, small interfering
RNA (siRNA)) screens offer an attractive strategy by which
to investigate such questions. They have previously been
used with success to identify mediators of Ras oncogene-
induced senescence, suppressors of p16 gene expression,
genes that regulate cell migration and cell survival genes in
mammary cells [13-16]. This type of investigation is
nevertheless dependent on a source of cells that can
be obtained in large numbers and readily transfected.
Because primary normal mammary epithelial cells, even
those derived from human mammoplasties, do not satisfy
either of these requirements, we sought an alternative in a
clonal diploid isolate of hTERT-immortalized cells [17] that
we found remains dependent on fibroblast stimulation
for its rapid growth when cultured at low density. By
combining automated imaging with siRNA screening
of these cells, we identified 43 signal-transducing receptors
and secreted factors with functionally validated roles in




Passage 6 184-hTERT polyclonal infection pool mammary
epithelial cells (obtained from [18]) were contributed to
the study by CB and LA. As described previously [18],
these pools were generated from anonymised primary
mammary epithelial sample 184 (see [18]) and not
subject to specific institutional review board approval.
We generated the monoclonal cell lines (184-hTERT-L9 or
184-hTERT-E11) and used the 184-hTERT-L9 cell line to
generate subsequent polyclonal cell lines (stably infected
with lentiviruses or NucLight Red (Essen BioScience,Ann Arbor, MI, USA), for example). The experiments
were conducted under University of British Columbia
Research Ethics Board protocols H06-0289, H06-0210
and B13-0126.
Cell culture
Passage 6 184-hTERT cells [18] were cloned in 96-well
plates and subcultured in serum-free mammary epithelial
cell basal media (MEBM; Lonza, Walkersville, MD, USA)
supplemented with the mammary epithelial cell growth
media in the SingleQuots kit (Lonza), 5 μg/ml trans-
ferrin (Sigma-Aldrich, St Louis, MO, USA) and 10−5 M
isoproterenol (Sigma-Aldrich), referred to as mammary
epithelial cell growth medium (MEGM).
Immunofluorescence
Multicolour fluorescence in situ hybridization (FISH) was
performed as previously described [19]. Immunofluores-
cence cell staining in three-dimensional Matrigel cultures
was performed as previously described [20] with pri-
mary antibodies to GM130 (BD Biosciences, San Jose,
CA, USA), CD49f and MUC1 (STEMCELL Technologies,
Vancouver, BC, Canada), as well as Alexa Fluor 680–
conjugated secondary antibodies (Invitrogen, Carlsbad,
CA, USA). Cells were counterstained with Oregon
Green 488 or Alexa Fluor 546 phalloidin (Invitrogen)
and DRAQ5 nuclear staining prior to imaging on a
confocal laser scanning microscope (Nikon Instruments,
Melville, NY, USA). For calcein acetoxymethyl ester
(calcein AM) and ethidium homodimer 1, 21-day
Matrigel cultures were stained unfixed for 20 minutes
and counterstained with Hoeschst 33342 (Invitrogen).
Immunofluorescence staining of cells in three-dimensional
Matrigel cultures cultured for 3 weeks was performed with
primary antibodies to E-cadherin (E-cad; Calbiochem,
San Diego, CA, USA), GM130 (BD Biosciences), CD49f
(STEMCELLTechnologies) and Alexa Fluor 680–conjugated
secondary antibodies (Invitrogen) and imaged on a
Nikon confocal laser scanning microscope. Colonies were
counted at five discrete, randomly chosen positions per
well using a Nikon confocal laser scanning microscope.
Only discrete, well-separated structures were counted. In
the cases where two colonies touched or merged, both
colonies were ignored for counting purposes. For caspase
3 staining, three-dimensional Matrigel cultures were
formalin-fixed and paraffin-embedded, and sections
were stained with caspase 3 antibody (Cell Signaling
Technology, Danvers, MA, USA). To quantify the propor-
tion of structures with wild-type epithelial organization
and polarization, RNAi-treated samples were scored and
compared to wild-type localization (see Additional file 1:
Figure S7 and Additional file 2: Figure S8A) for examples
of each category. For CD49f, the presence of a single base-
ment membrane type of immunoreactive structure was
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wild-type polarization was deemed to be signal-localized
between the edge of the colony and an unstained
lumen. Lack of polarization would be reflected in the
indistinguishable staining patterns between the outer
and inner cell layers.
Genome-wide siRNA screen protocol
Black-walled clear-bottom 96-well plates (Greiner Bio-One,
Monroe, NC, USA) were seeded with 3,000 freshly irradi-
ated NIH 3T3 cells per well in Dulbecco’s modified Eagle’s
medium with 5% foetal bovine serum. After 24 hours, the
medium was aspirated at a low flow rate with a multichan-
nel vacuum aspirator and replaced with 550 184-hTERT-L9
cells per well in MEGM without bovine pituitary extract
(BPE) added. After an additional 24 hours, Lipofectamine
2000 reagent–siRNA complexes were generated.
siRNAs were purchased from the siGENOME library
(Dharmacon, Lafayette, CO, USA) as deconvolved sets
of four individual siRNAs and resuspended at 10 μM in
1× siRNA buffer (Dharmacon) as described elsewhere
[21]. Lipofectamine 2000 transfection reagent (Invitrogen)
was diluted in MEBM and incubated for 5 minutes prior
to mixture with an equal volume of prediluted siRNA in
MEBM. Complexes were allowed to form for 20 minutes
before they were added directly to the cells at a final
concentration of 30 nM siRNA and 0.3 μl of transfection
reagent per well. The control wells were static in position
and were composed of Lipofectamine alone, siControl-3
and a siRNA pool targeting PLK1. The entire 96-well
plates of these controls were staggered throughout the
duration of this screen to allow for statistical correction of
plate positional effects. After an additional 4 days of
growth, cells were fixed with 4% paraformaldehyde and
stained with 1 μg/ml 4′,6-diamidino-2-phenylindole
(DAPI) prior to being imaged on an IN Cell Analyzer
(GE Healthcare Bio-Sciences, Pittsburgh, PA, USA)
using the 10× lens objective (numerical aperture, 0.45)
with charge-coupled device pixel binning. Twenty-one
fields per well were collected using HQ360/40 excitation
and HQ535/50 emission filters with a multi-bandpass
dichroic filter (Q505lp; Chroma Technology, Bellows
Falls, VT, USA). For each image field, a single focal plane
was captured using a hardware (laser/photodetector)
autofocusing algorithm, which estimated the surface area
on which the cells were lying. An image segmentation and
postprocessing software workflow was developed using
CellProfiler [21]. Cell counts per well produced in the
Cell Profiler image analysis were further processed using
quantile normalization to correct for data distributional
differences induced by factors such as time-dependent
stain degradation and other plate-handling artefacts.
Quantile-normalized data were then analysed using statis-
tical linear mixed effects regression models to comparecell counts under the siRNA condition with counts under
the control condition, adjusted for technical artefacts of well
position and plate effects, thereby yielding plate-normalized
growth effect estimates for each siRNA. Well position
effects were assessed by screening additional plates
containing the same control condition in all wells.
Plate effects were assessed by using multiple plates
for each condition, thereby allowing for adjustment of
plate-to-plate variability in the statistical model. The
model-estimated cell count under the siRNA condition
was then divided by the model-estimated cell count under
the control condition to produce an overall measure of
relative effect. Measured effects were ranked from smallest
to largest, and the latter (those reducing cell growth by
75% or more) were selected for further study. Enrichment
network analysis was performed as previously described
[22] using the Reactome Functional Interactome plugin in
Cytoscape v2.8.1 [23,24].Lentiviral transduction procedure
184-hTERT-L9 cells were transduced at an estimated
multiplicity of infection (MOI) of 5:1 with 8 μg/ml poly-
brene. After 18 hours at 37°C, cells were washed, and,
after 24 hours in MEGM, they were selected with 2 μg/ml
puromycin in MEGM (replaced every 24 to 48 hours).
Dissociated primary human mammary epithelial cells were
infected with an estimated MOI of 10. Transduction was
conducted in suspension with 8 μg/ml polybrene at a
density of 5 × 105 cells in 100 μl of serum-free 7
medium (DMEM/F12 (STEMCell Technologies) sup-
plemented with 5% FBS, 2 mM glutamine (Gibco), 0.1%
w/v BSA, 10 ng/ml EGF (Sigma), 10 ng/ml cholera toxin
(Sigma), 1 μg/ml insulin (Sigma), 0.5 μg/ml hydrocorti-
sone (Sigma)) with 50 μg/ml GA-1000 (Lonza). After 18
hours at 37°C, cells were washed and counted and equal
numbers plated into two-dimensional colony-forming
cell assays.Primary mammary tissue
Discarded tissue was collected from premenopausal
women (ages 19 to 40 years) who provided informed
consent as approved by the University of British
Columbia Research Ethics Board, as previously described
[2]. Suspensions selectively enriched in bipotent progeni-
tor cells were obtained by fluorescence-activated cell
sorting (FACS) of cells positively costained with an
allophycocyanin-conjugated rat antibody to human CD49f
(eBioscience, San Diego, CA, USA) and a phycoerythrin-
conjugated mouse antibody to human epithelial cell adhe-
sion molecule (EpCAM; eBioscience) [2]. Hematopoietic
stem cells and endothelial cells were eliminated using anti-
bodies to human CD45 and human CD31 (eBioscience),
respectively.
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incorporation
To determine the proliferation rate, 184-hTERT-L9 cells
stably infected with NucLight Red were seeded into wells
of 24-well plates (16,750 cells per well). Twenty-four
hours after plating, the cells were transfected with siRNAs
(30 nM concentration) and cultured in the IncuCyte
ZOOM incubator (Essen BioScience). Twenty hours after
transfection, the siRNA-containing medium was removed
and replaced with standard 184-hTERT culture
medium. Sixty-eight hours after transfection, 5-ethynyl-
2′-deoxyuridine (EdU) was added to each well to a final
concentration 40 μM. After 1 hour, wells were washed
with phosphate-buffered saline, then the cells were
harvested with a trypsin/ethylenediaminetetraacetic acid
mixture. To ensure sufficient cell numbers for FACS,
1 × 105 nonfluorescent 184-hTERT cells were added to
the cells harvested from each well. EdU incorporation
was then detected by staining with the Click-iT EdU
Alexa Fluor 488 Flow Cytometry Assay Kit (Life
Technologies, Grand Island, NY, USA) according to the
manufacturer’s instructions, followed by FACS acquisition
on a BD FACSAria III cell sorter (BD Biosciences). DAPI
was used to detect DNA content and to gate out cell
fragments. The percentage of test cells that incorporated
EdU was determined by gating on the NucLight
Red–positive cell population and applying an EdU-positive
gate set with reference to negative control (carrier) cells
processed with the Click-iT EdU assay but not previously
exposed to an EdU pulse.
Determination of proliferation and apoptosis by live cell
imaging
Where appropriate, 184-hTERT-L9 cells were stably
infected with NucLight Red, which marks the nuclei red
to distinguish them from unlabelled irradiated feeders
used the in co-culture experiments. To control for
feeder effects, we conducted the experiment using both
feeder-free and feeder-containing conditions, with BPE
medium supplement (see details in methods) used for
the nonfeeder condition. For the feeder-present condi-
tion, 3,000 irradiated feeders per well were plated in
96-well plates 24 hours prior to plating 550 184-hTERTs
stably expressing NucLight Red. Transfection of 30 nM
siRNA (complexing as described in methods) was per-
formed 24 hours later, and the complexes were washed
out after 24 hours, with the addition of CellPlayer
Caspase-3/7 reagent (Essen BioScience), which labels
apoptotic cells green, detecting caspases 3 and 7. The plate
was then imaged using an IncuCyte ZOOM live cell
microscope (Essen BioScience), and images were taken
every 4 hours for an additional 84 hours. The data were
analysed as follows. Triplicate red cell objects (represent-
ing hTERT with NucLight Red) and green objects(apoptotic cells with activated caspase 3, as the percentage
of red objects) were counted (counts per square milli-
metre) using the GraphPad Prism statistical software suite
(GraphPad Software, La Jolla, CA, USA), and the respect-
ive areas under the curve (AUCs) for serial measurements
were calculated. Where comparisons were made, the AUC
values were subjected to a one-way analysis of variance test
to compare the mean of each siRNA to the control
condition, in which only Lipofectamine 2000 transfection
reagent was used to determine significance.
Gene association analyses
Expression and patient outcome data for 1,996 breast
cancer patients were obtained from the Molecular
Taxonomy of Breast Cancer International Consortium
(METABRIC) study (European Genotype-phenome Archive
study accession number: EGAS00000000083) [25]. Relative
hazard estimates for cases with high versus low gene
expression were obtained using a Cox proportional hazards
model with the binarized expression variable and stratified
by integrative cluster (IntClust) breast cancer subtype
groups to mitigate for the nonproportional hazards
exhibited between various IntClust groups. Expression
variables were binarized at the 15%, 25%, 50% and
75% quantiles, and Akaike information criteria (AIC)
were calculated using a Cox model containing the
binarized expression variable. The binarization cut
point was chosen as the quantile yielding the minimum
AIC value. In the case that the minimum and maximum
AIC values differed by less than 3.0, the median expres-
sion level was used as the cut point to ensure adequate
case counts within the breast cancer subtype groups. To
identify potential instances of interaction between expres-
sion level and breast cancer subtype (high versus low
expression showing improved survival in one subgroup and
poorer survival in another subgroup), a Cox model with
binarized expression, IntClust subgroups and their inter-
action terms was fitted and compared to a Cox model con-
taining IntClust subgroups only, yielding an omnibus test
of survival difference due to the biomarker. P-values across
all 46 fitted models were adjusted for multiple comparisons
using the method of Benjamini and Hochberg [26], and sig-
nificant findings after adjustment for multiple comparisons
were identified. To guard against the issue of changing
hazards over time and nonproportional hazards between
IntClust subgroups, each binarized biomarker was tested
using the G-rho rank test procedure stratified by IntClust
subgroups and setting ρ = 1 to place heavier weight on
earlier time point observations [27]. P-values from all 46
G-rho tests were adjusted for multiple comparisons, and
genes with low false discovery rates were identified.
For analysis of transcripts in flow-sorted mammary
epithelial cell lineages, we made use of the NIH and
Canadian Roadmap Epigenomics mammary epithelial
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protocols and data can be accessed online [28,29].
The flow sorting of mammary epithelial subsets was
performed using CD10, MUC1 and CD73 as described
previously [30].
Expression data
Expression data processing and normalization are described
in the supplementary materials of the METABRIC study
[25]. Expression data were additionally centred and scaled
within the study data centre as follows:
rijk ¼ eijk−medikigsjk
where eijk is the normalized expression value for subject i,
gene target j, in data centre k; medik is the median
expression value for gene target j in data centre k;
and igsjk is the interquartile spread for gene target j
in data centre k. (Interquartile spread is the difference
between the 75th-percentile value and the 25th-percentile
value, a robust measure of standard deviation.) Heat maps
of this robustly centred and scaled data were generated
with complete linkage clustering of gene targets indicated
on the vertical axis. To yield comparable colour schemes
across all genes in the heat map, values less than −3.0 were
set to −3.0 and values greater than 3.0 were set to 3.0.
Expression value differences among breast cancer sub-
type groups (IntClust and PAM50) were assessed using
the Kruskal-Wallis test. Beanplots [31] of expression values
within breast cancer subtype groups for each of the 47 final
identified gene targets were ordered in Kruskal-Wallis test
P-value order.
Results
Isolation and characterization of a cytogenetically normal
clone of 184-hTERT cells
We sought a cell line model of primary human mammary
epithelial cells that would display fibroblast-enhanced
growth at low cell density and would also be readily
amenable to high-throughput, genome-wide genetic
manipulation. Preliminary data indicated that this was
a retained feature of 184-hTERT cells. However, those
widely available are karyotypically abnormal and may be
chromosomally unstable [32]. Therefore, we obtained an
early passage of the original 184 primary cell pool trans-
duced with hTERT [17]. After cloning approximately
80 independent lines, we isolated a clone (184-hTERT-L9)
in which all cells showed a stable normal (46, XX)
karyotype, a copy number diploid genome (Figure 1A
and Additional file 3: Figure S1D) and a basal phenotype
(K5+, E-cad+, MUC1− and oestrogen receptor α–negative
(ERα−)) (Additional file 3: Figures S1B and S1C) with
expression of epidermal growth factor receptor and E-cad(Additional file 3: Figure S1B), but not of keratin 18,
human epidermal growth factor receptor 2 (HER2) or ERα
(Additional file 3: Figures S1B and S1C). 184-hTERT-L9 cells
also express wild-type p53 (Additional file 3: Figure S1B),
but they show silenced p16 expression (Additional file 3:
Figure S1C) and have a single integration site for hTERT
(Additional file 3: Figure S1A).
To quantify fibroblast-dependent growth [33-35], we
compared 184-hTERT-L9 cells with primary basal progeni-
tor cell-enriched fractions (CD49fhighEpCam−) sorted from
dissociated reduction mammoplasty tissue. When plated in
a colony-forming cell assay in co-culture with an increasing
density of irradiated fibroblasts, a dose-dependent growth
response was observed (Figure 2) for both 184-hTERT-L9
and primary mammary epithelial cells at low plating
densities. This behaviour is distinct from many immortal-
ized mammary epithelial cells lines, including MCF10A
(Figure 2), in which colony formation at low epithelial
cell density occurs with high efficiency independent
of a fibroblast feeder layer (growth at 0 fibroblasts).
We next compared the three-dimensional growth
characteristics of 184-hTERT-L9 with flow-sorted pri-
mary mammary epithelial cells and with MCF10A cells
[36]. When placed into three-dimensional Matrigel cul-
ture, 184-hTERT-L9 cells formed spherical, multilayered
acini with apicobasal polarity, as determined by staining
with antibodies raised against apical marker GM130 and
basal marker CD49f (Figure 1B). The immunoreactivity
of inner cells with antibodies to the luminal marker
protein MUC1 suggests that differentiation is multilineage.
A key element of three-dimensional mammary differenti-
ation is the death of cells forming the lumen of spherical
acini. This was observed using calcein AM and ethidium
homodimer 1 staining of unfixed three-dimensional
cultures (Figure 1B). As with primary bipotent mammary
epithelial progenitors [3], 184-hTERT-L9 acini exhibit
squamous differentiation of the inner cells in three-
dimensional Matrigel cultures, which is appreciable by
the morphology of the inner cells stained with phal-
loidin (Figure 1B). The similarities and differences
between 184-hTERT-L9 and MCF10A cells are shown in
Additional file 4: Table S1.
Defining the genes required for mammary epithelial cell
growth under co-culture conditions
To identify genes involved in the regulation of mammary
epithelial cell growth, we used the 184-hTERT-L9 cells
in a co-culture (fibroblasts and epithelial cells, defined
medium without serum) genome-wide siRNA screen
using 21,121 pools of siRNAs designed to the human
genome (Dharmacon). The primary screen was used for
initial hit identification, and multiple secondary screens
focused on transmembrane and extracellular protein











Figure 1 (See legend on next page.)
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Figure 1 184-hTERT-L9 cells have a normal karyotype and form acini in three dimensions. (A) 184-hTERT-L9 cells were arrested in
metaphase using colcemid prior to multicolour fluorescence in situ hybridization analysis. Metaphase spreads had a normal diploid chromosome
complement devoid of numerical or structural changes (n = 7). (B) Cells cultured in three-dimensional Matrigel were fixed after 21 days and
probed with antibodies targeting GM130 (apical polarity), CD49f (basal polarity) and MUC1 (luminal marker). Either Oregon Green–labelled
phalloidin or an antibody targeting E-cadherin was used as a counterstain, with DRAQ5 nuclear stain. For viability assessment, unfixed structures
were incubated for 20 minutes with calcein AM, ethidium homodimer 1 (EthD-1) and Hoechst 33452 immediately prior to being imaged on a
Nikon confocal laser scanning microscope.
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secondary screening assays (Figure 3A), a layer of
freshly irradiated murine NIH 3T3 cells was left to
adhere for 24 hours prior to addition of a low density
of 184-hTERT-L9 cells. After an additional 24 hours,
these co-cultures were robotically transfected with the
siRNA pools. Although two cell types were present in
the assay, two features of the assay were used to bias
the primary screen RNAi responses to the epithelial
cells. First, the transfection conditions used for the
epithelial cells were not capable of efficiently inducing
RNAi transcript/protein knockdown in irradiated fibroblast
cells (Additional file 5: Figures S3B and S3C), even with
species-specific siRNAs (murine β-actin for NIH 3T3 cells,
human GAPDH for IMR-90). The reduced capacity of
irradiated versus nonirradiated fibroblasts to mediate RNAi
was further demonstrated (Additional file 5: Figures S3A
and S3D) using universally cell-lethal positive control
siRNA (siTOX; Dharmacon) and siRNA to PLK, showing
that irradiation abrogates the functional effects of these
positive controls (Additional file 5: Figure S3D), although
irradiated fibroblasts are still capable of executing cell
death programs. Second, the siRNA library used is
human-specific, whereas the fibroblasts are mouse-derived,
so any siRNAs entering the cell would be of reduced effect-
iveness. It is important to note that, in order to confirm
that growth effects were related to gene activity in the
epithelial cells, all subsequent secondary screen revalidation
experiments were carried out either in feeder-free condi-
tions or with transfection into epithelial cells undertaken
before placement onto a feeder layer. To quantify cell
growth, we counted the number of nuclei per well 4 days
after transfection with automated image recognition in
duplicate assay plates [21]. In the co-culture conditions
we used, changes in total nuclear count reflected the
number of epithelial cells present, irrespective of the
fixed number of nondividing feeder cells present per well
(Additional file 6: Figure S2A).
The primary screen (two replicates per condition)
resulted in the identification of 2,337 genes (of 21,121
(11.1%)) in which knockdown led to a statistically significant
decrease (adjusted P-value <0.05 by Benjamini-Hochberg
analysis) in cell growth to less than 25% of the control
condition (Figure 3B and Additional file 7: Table S2A). We
noted that several receptors for required components of thedefined growth media were ranked in the top 50%
(Figure 3B) of growth effects (insulin, epidermal growth
factor (EGF), isoproterenol and transferrin). Enrichment
map analysis using the Reactome Functional Interactome
plugin in Cytoscape v2.8.1 [23,24] of the genes ranked by
primary screen growth inhibition showed four statistically
significant linked networks (Figure 4) and several singletons.
As expected, the largest network implicated cell cycle
functions; however, we also noticed a multinode network
and several singleton nodes representing G protein–coupled
receptor (GPCR)-mediated transmembrane signalling.
We therefore focused on further analysis of genes with
subcellular location annotations [37] (Additional file 7:
Table S2B) that indicated the presence of transmembrane,
extracellular, and secreted proteins (388 genes with
greater than 75% primary growth inhibition). To con-
trol for clonal cell line effects, we performed a sec-
ondary screen with these 388 genes (using a co-culture
assay as primary screen) with both 184-hTERT-L9 and
184-hTERT-E11, a sister clonal cell line to 184-hTERT-L9
with identical growth characteristics, but with a different
hTERT integration site. Of these 388 genes, 140 (36% of
those retested) were considered reproducible in that they
produced the same magnitude of growth reduction upon
reassessment in the secondary screen (Figure 3C) in one
or both clonal cell lines. We determined which of the 140
screen-reproducible siRNA pools were likely acting on
target initially by quantitative RT-PCR (qRT-PCR) to
determine which siRNA pools resulted in significant target
transcript knockdown 48 hours after transfection into
184-hTERT-L9 cells. For this purpose, cells were grown in
BPE as opposed to co-culture with irradiated feeder
cells to reduce interfering mRNA signals. We found that 47
(33.6%) of 140 of the siRNA pools achieved statistically
significant mRNA silencing (adjusted P < 0.05 by Benjamini-
Hochberg analysis) (Additional file 7: Table S2C), and these
were designated as the target genes for further study.
Additional validation was conducted as follows. (1)
We deconvolved each siRNA pool to individual
siRNAs and noted that in 20 (42.5%) of 47 of the
siRNA sets, at least three of the individual siRNAs
produced a statistically significant decrease (adjusted
P < 0.05 by Benjamini-Hochberg multiple comparisons
method) (Additional file 7: Table S2C) in growth within
the two-dimensional co-culture assays. (2) We tested
Figure 3 High-throughput screen for genes regulating mammary epithelial cell growth. (A) Summary of screen and follow-up assays
leading to the identification of 47 candidate target genes. (B) Ranked distribution of growth effects for small interfering RNA (siRNA) pools utilized
in the siRNA screen, normalized to the Lipofectamine 2000 (LF2K) reagent-alone control condition. Pooled siRNAs with a statistically significant
effect that reduced growth to 25% or less of the control condition are highlighted in blue. (C) Ranked distribution of growth effects for siRNA
pools utilized in the secondary screen targeting genes on the plasma membrane and in the extracellular space. Pooled siRNAs with a statistically
significant effect in 184-hTERT-L9 and/or 184-hTERT-E11 cells that reduced growth to 25% or less of the control condition are highlighted in red.
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Figure 2 Fibroblasts influence mammary epithelial cell growth. Colony-forming assays were performed with an increasing density of
irradiated NIH 3T3 cells plated alongside a set density of prospectively fractionated human bipotent mammary progenitor cells (black; n = 6 patient
samples), 184-hTERT-L9 cells (blue; n = 4) and MCF10A cells (red; n = 4). The whisker ends on the box plots denote the lowest and highest data within
1.5× the interquartile range of the lower and upper quartiles, respectively.


















































































Figure 4 Network analysis of genes important in epithelial cell growth. Enrichment map of the top-ranking clusters of genes within the
primary screen data that reduced growth to 25% or less of the control condition, as determined with the Reactome Functional Interactome
plugin in Cytoscape v2.8.1. APC/C, Anaphase-promoting complex; GPCR, G protein–coupled receptor; IL2, Interleukin 2; NF-KB, Nuclear factor κB;
PI3K, Phosphatidylinositol 3-kinase; TNF, Tumour necrosis factor.
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short-hairpin RNA (shRNA) constructs for each of the 47
target genes. One to three shRNA constructs from the
GIPZ human lentiviral shRNA library (Dharmacon) were
selected for analysis [38], and shRNAs were transduced in
BPE-supplemented medium to maximize the potential
of rescuing growth and formation of stable clones.
Stably growing clones could not be isolated from 29
shRNAs covering 24 genes, suggesting the inability of
these cells to grow upon gene silencing of these
genes (verified by qRT-PCR in short-term culture;
see Additional file 7: Table S2D), even with BPE
present in the medium. Even among the stable clones
derived, fibroblast-dependent growth was reduced. In
total, 34 (72.3%) of 47 of the transmembrane and/or
extracellular space protein encoding transcripts appeared
to be required for epithelial cell growth, as determined by
siRNA pool deconvolution and/or by knockdown with a
second gene RNAi method (shRNA) (Additional file 6:
Figure S2B and Additional file 7: Table S2C).
The increase and decrease in cell numbers observed in
the primary and secondary screens likely resulted from amix of proliferation (cell division) and apoptosis. To
determine the relationship and relative contribution of
these two factors, we quantified caspase 3/7 activity and
proliferation simultaneously by using high-content live
cell imaging (see IncuCyte ZOOM description in the
Methods section). We observed that there was an
inverse correlation (Additional file 8: Figure S4B (rank
correlation −0.954) and Additional file 9: Figure S5
(rank correlation, −0.959)) between caspase activity
and the rate of cell increase (determined as AUC over
time). We verified that cell proliferation measured by
high-content live cell imaging as AUC over time
was positively correlated with the fraction of cells in
S-phase, which we determined by EdU incorporation
(Additional file 8: Figure S4A (rank correlation,
0.735)). The relationship between caspase activation
and proliferation was similar, regardless of whether the
epithelial cells were grown in feeder-free conditions
(Additional file 8: Figure S4B) or with a feeder monolayer
(Additional file 9: Figure S5) (feeder to no-feeder rank
correlation, 0.892; P < 1 × 10−5 in randomization test).
Taken together, these data show that the genes of greatest
Burleigh et al. Breast Cancer Research  (2015) 17:4 Page 10 of 21effect on cell growth tend to affect both proliferation
(cell cycle) and caspase activation (apoptosis). Some
exceptions were noted, such as the EDG (LPAR3) receptor,
where the effect on proliferation was higher in rank than
the degree of apoptosis.
Functional annotation clustering was performed using
the DAVID Bioinformatics Database, with enrichment
based upon the Gene Ontology biological process for
the 47 genes required for 184-hTERT-L9 growth [39].
Enrichment scores were generated based upon the
functional classification of these genes and denote the
relatedness of a seemingly heterogeneous group of
genes (Additional file 7: Table S2F). Notably, a number of
guidance factors required for neuronal development are
necessary for fibroblast-driven mammary epithelial cell
growth [40,41]. Also enriched are clusters of genes
involved in axon guidance, signal transduction through
protein kinase cascades, intracellular ion homeostasis,
GPCR signalling and cell migration (Additional file 10:
Figure S6B). Additional file 10: Figure S6A displays the
axon guidance pathway in which SEMA3C, and part of its
receptor complex, PLXNA2, ROBO3, EFNA4, NTN1 and
NTN2L from our target gene list, are all highlighted. Axon
guidance molecules are increasingly recognized to play
a role in mammary gland development and breast tumouri-
genesis [42], and our data significantly strengthen this asso-
ciation. We considered the possibility that some of the 47
genes identified may have differential expression in the
luminal and basal developmental lineages, and therefore we
inspected flow-sorted RNA-seq libraries of mammary
lumen and myoepithelium (three independent pairs from
the RNA-seq library; see Additional file 11: Table S3 and
discussion of NIH Canadian Roadmap Epigenomics
mammary epithelial cell RNA-seq libraries in the Methods
section). However, no statistically significant differences
were observed (Holm-Bonferroni-adjusted P-values >0.05).
Distinct requirements for transmembrane and/or
extracellular genes in three-dimensional epithelial cell
growth and differentiation
The response of mammary epithelial cells to mitogens
and cellular signalling can differ dramatically when cells
are grown on solid supports or feeder layers, as opposed
to within a three-dimensional context embedded in
extracellular matrix (Matrigel) [43,44]. Using short- and
long-term cultures (with defined media and no BPE
supplements) in Matrigel assays, we sought to determine
which of the 47 gene transcripts identified as modulating
epithelial cell growth in the co-culture assay were also
required for three-dimensional growth and differentiation.
First, using acinar formation in short-term culture as a
growth measure (that is, counting three-dimensional
structures formed after plating cells at low density, as
in a two-dimensional colony-forming assay), we determinedthe requirement for each gene using siRNA knockdown. As
siRNA transfection complexes cannot effectively penetrate
Matrigel, we transfected cells in culture for 48 hours prior
to harvesting and replating them in Matrigel [45]. We
determined that siRNA silencing was effective for up to
10 days in Matrigel cultures of 184-hTERT-L9. The
number of acini compared to a nontargeting siRNA
control was enumerated after 8 days in culture (Figure 5).
All but four genes (ADCY4, PCDHB13, KCNJ5 and
FLOT2) showed significant (P < 0.001 with Dunnett’s
adjustment) reductions of growth in three dimensions,
and three genes (HSD17B2, PROCR and SNN) showed
more than tenfold reductions in the number of acini. We
noted that, despite having the greatest effects on three-
dimensional growth, PROCR (31.6-fold decrease in three
dimensions; 95% confidence interval (CI), 14.0 to 163.8)
and HSD17B2, a transmembrane-linked enzyme required
for oestrogen and testosterone steroid biosynthesis
(27.3-fold decrease in three dimensions; 95% CI, 10.0
to 163.9) were consistently in the third or fourth
quartile of effects on two-dimensional growth in both
the primary and secondary two-dimensional screens
in comparison to the final 47 target genes. In all genes, the
magnitude of growth modulation in two dimensions did
not correlate with the magnitude of three-dimensional
growth change (Additional file 7: Table S2C).
The requirements for three-dimensional growth are
distinct from monolayer cultures, and the process of
acinar formation can be disrupted for many reasons.
In the second approach, we sought to determine if
three-dimensional effects were limited solely to growth by
looking at acinar formation after 21 days when polarization
and lumen formation have occurred. For a 21-day culture,
long-term RNAi is required, and we therefore exam-
ined shRNA stable lines in which growth could be
rescued (for initial clone generation) by BPE media
supplements. Among the three genes showing the
greatest effects on acinar formation, SNN, HSD17B2 and
PROCR (Additional file 7: Table S2C), the shRNAs
inhibited growth to a degree precluding derivation of
stable clones for all but PROCR. The PROCR stable
clone exhibited a 14.1-fold (99% CI, 7.16 to 28.57;
RQ Manager software; Applied Biosystems, Foster
City, CA, USA) compared to nontargeting controls
(Additional file 7: Table S2D). When placed into a
quantitative two-dimensional co-culture assay, growth
was decreased 3.73-fold (95% CI, 3.38 to 4.16; Student’s
t-test) in comparison to a stable cell line generated
with a nontargeting shRNA construct.
After plating control and PROCR-knockdown clones in
Matrigel, the number of acinar structures was decreased
compared to the control nontargeting shRNA. Those acini
that formed did so abnormally. These acini lacked the







Figure 6 PROCR expression is necessary for cell organization and luminal clearance in three-dimensional culture. 184-hTERT-L9 cell lines
with stable integration of pGIPZ short-hairpin RNA (shRNA) lentiviral constructs against PROCR or a nontargeting control were seeded into
three-dimensional Matrigel culture and fixed after 21 days of growth. Staining was performed with Alexa Fluor 546–conjugated phalloidin and
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Figure 5 Genes that modulate two-dimensional co-culture growth are also important in anchorage-independent three-dimensional
growth. Three-dimensional Matrigel culture assays were performed with 184-hTERT-L9 cells after they were transfected with small interfering RNA
(siRNA) pools targeting the 47 genes required for mammary epithelial cell growth. The acini (with an acinus defined as a ball of 50 cells or more)
formed per well were counted 8 days postplating, and surviving fraction estimates were generated in comparison to both transfection reagent-only
and nonsilencing siRNA controls. Acini count fold changes are plotted as a rank relative to the control mean. Fold changes were calculated as mean
number of acini when the gene was silenced in three-dimensional cultures divided by the mean number of acini when siRNA and transfection reagent
controls were used in three-dimensional cultures. Error bars represent 95% confidence intervals (n = 4).
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Figure 7 LPAR3, but not LPAR1 or LPAR2, is necessary for
two-dimensional and three-dimensional mammary growth.
Equal numbers of 184-hTERT-L9 cells transfected with small interfering
RNA (siRNA) pools against three lysophosphatidic acid (LPA) receptors
(LPAR1, LPAR2 and LPAR3), transfection reagent alone and PLK1 (as a
positive control) were plated in two-dimensional colony-forming
assays (n = 3) (A) and three-dimensional Matrigel cultures (n = 4)
(B). Cells were counted after 8 days in culture. Error bars represent
95% confidence intervals.
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with the nontargeting shRNA (Figure 6), indicating a
role for PROCR in mammary epithelial differentiation,
organization and growth. To further explore the effects on
three-dimensional differentiation and epithelial organization,
we quantified the degree of polarization and lumen
formation for PROCR, EFNA4, LGALS1 and NTN1.
Knockdown of all four genes resulted in increased disrup-
tion of GM130 localization (70% to −88% nonpolarized
structures compared to 14% for nontargeting siRNA)
(Additional file 1: Figure S7 and Additional file 2:
Figures S8A and S8B); however, only LGALS1 knockdown
showed significant disruption of lumen formation (50%
nonhollow compared to 8% to 17% for other genes and
nontargeting siRNA) (Additional file 1: Figure S7 and
Additional file 2: Figures S8A and S8B). PROCR was
the only gene for which knockdown resulted in significant
disruption of CD49f basal localization (100% structures dis-
rupted) (Additional file 1: Figure S7 and Additional file 2:
Figures S8A and S8B). Taken together, these results
suggest that several of the genes identified may have
roles in differentiation and development of multilayered
mammary epithelium.
Strikingly, both the two-dimensional and three-
dimensional assays showed that several GPCRs appeared
to be required for epithelial cell growth, including LPAR3,
one of three major receptors for lysophosphatidic acid
(LPA). In transgenic mouse models, overexpression of
each of these individual LPA receptors (LPAR1, LPAR2
and LPAR3) under the control of the mouse mammary
tumour virus long terminal repeat (MMTV-LTR)
promoter led to the formation of late-onset mammary
carcinomas [46]. However, our screen of nontransformed
human epithelium did not initially identify a role for either
LPAR1 or LPAR2 in mammary epithelial cell growth. To
verify this, we used siRNA pools to silence LPAR1, LPAR2
and LPAR3 expression in 184-hTERT-L9 cells prior to
plating the cells in colony-forming assays. In keeping with
the primary siRNA screen results, LPAR3 was required for
mammary epithelial cell growth, with moderate growth
effects in the colony-forming assay identified when LPAR2
was silenced (Figure 7A). Additionally, in three-dimensional
culture conditions, silencing of LPAR1 or LPAR2 did not
affect acinar formation, whereas we observed a complete
abrogation of three-dimensional growth when LPAR3 was
silenced in 184-hTERT cells (Figure 7B).
Requirement of screen-identified transmembrane and/or
secreted genes for primary mammary progenitor cell
growth
To address the question whether the growth dependency
identified in the cell lines is mirrored in primary
mammary epithelial cells, we tested 29 of the 47 target
genes described above for their ability to diminish thein vitro growth of human primary mammary progenitor
cells. The strategy employed was to transduce primary
epithelium–enriched, but otherwise unsorted, cells
obtained from dissociated reduction mammoplasties
(see the Methods section for details) and to assay the
luminal and basal cell epithelial lineages by scoring
colony types in colony-forming assays [10,47-50]. All
of the shRNA constructs tested produced statistically
significant silencing of the mRNA transcript of interest in
epithelial cells (Additional file 7: Table S2D). Transduction
efficiency in unsorted primary tissue, as gauged by green
fluorescent protein (GFP) expression from the pGIPZ
lentiviral vector backbone, was 28.3% (95% CI, 20.2% to
36.1%). Three patient samples were evaluated in technical
duplicates for each target gene to compare the effect of
the target shRNA to that of a nonsilencing control
shRNA. The total number of colonies produced from both
Figure 8 Genes modulating 184-hTERT-L9 co-culture growth
also affect primary human mammary epithelial cell growth.
Single-cell suspensions of dissociated human primary mammary cells
were infected with individual short-hairpin RNA (shRNA) constructs
targeting our screen-identified gene set prior to being plated in
colony-forming assays. The fraction of surviving colonies after silencing
of the target genes relative to a nontargeting shRNA control is plotted.
Error bars represent 95% confidence intervals (n= 3 patient samples).
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calculate the fraction of surviving colonies (see the
Methods section for details) after silencing of the target
genes (Figure 8). The high patient-to-patient variability in
primary epithelial cell growth is a feature that constrained
the quantitative assessment of primary cell growth effects;
for example, LPAR3 did not show a statistically significant
growth difference. Nevertheless, the data showed a range
of quantitative effects on colony formation of cells derivedfrom primary epithelium, with more than two-thirds
of the genes exhibiting a median decrease in colony
formation and two genes showing a statistically significant
decrease in surviving fraction (GPR39 and NTN1; 2.19-fold
and 3.33-fold decreases, respectively).
Expression of screen-identified genes among breast
cancer subtypes
Genes regulating growth and differentiation are important
components of the cell type landscape on which malignant
transformation occurs in human cancers. One indication of
this is the cosegregation of gene expression with biological
subtypes of cancer. To address this question for the genes
identified in relation to epithelial cell growth, we examined
the distribution of transcript expression by subtype across
1,998 breast cancer patients [25] for whom mRNA expres-
sion has been measured, alongside other features of the
genome and with clinical outcomes. Within the last year,
the METABRIC study and related genomic landscapes
have redefined the number of biologically distinct primary
breast cancer subtypes [22,25,51-55]. Using these data and
10 recently defined biological primary breast cancer
subgroups, we examined the expression levels of the 47
screen-identified genes (Figure 9A and B, Additional file 7:
Table S2C and Additional file 12: Figure S9). The relation-
ship to the five PAM50 breast cancer subgroups was also
calculated (Additional file 13: Figure S10).
We examined each gene individually for subtype-specific
expression. Significant differences in expression distribution
were seen for 40 of the 47 genes across the 10 METABRIC
datasets (Figure 9B and Additional file 12: Figure S9)
(Kruskal-Wallis-adjusted P-value <0.05, Benjamini-Hochberg
multiple-comparisons method) and for 39 of the 47
genes in the PAM50 groups (Additional file 13: Figure S10)
[25]. Several genes (for example, RIPK2, EFNA4 and
TMEM9B) (Figure 9B, Additional file 12: Figure S9 and
Additional file 13: Figure S10) showed differential expres-
sion in subtypes associated with high proliferation, such as
IntClust 5 (predominantly HER2/ERBB2-amplified cancers)
and IntClust 10 (predominantly basal expression type
cancers). However, other breast cancer groups (IntClust 4,
6, 7 and 8, predominantly ER+ subtypes) (Figure 9A and B,
Additional file 7: Table S2B) also showed significant
enrichment for over- and underexpression of several genes.
We noted that 21 of 47 genes required for 184-hTERT cells
lie within chromosomal hotspots for copy number amplifi-
cation (Additional file 7: Table S2C). All 47 genes have pre-
viously identified mutations in human tumours, and 18 of
these genes have known mutations in breast tumour tissues
(Additional file 7: Table S2C) [56,57].
To test the group as a whole, we also performed a
randomization simulation study to assess the strength of
association demonstrated by this set of 47 genes within
the 10 IntClust subtypes. In 10,000 simulation runs,
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Figure 9 (See legend on next page.)
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Figure 9 Genes identified though screening are differentially expressed across breast cancer subtypes. (A) Expression levels of the 47
genes found to be required for mammary epithelial cell growth are displayed on a heat map representing 1,998 breast cancer patients within the
METABRIC dataset. Gene expression was determined on the Illumina HumanHT-12 Expression BeadChip array (Illumina, San Diego, CA, USA). Cases
are clustered according to ten biological primary breast cancer subgroups described in Additional file 2: Figure S8 (also see [25]). (B) Beanplots
depicting target gene expression in the ten biological primary breast cancer subgroups for RIPK2, TUFT1, EFNA4 and TMEM9B. The individual
observations are shown as small horizontal lines in a one-dimensional scatterplot with the estimated density of the distributions shown in colour
and the average indicated by the long horizontal line. (C) Rank-ordered plot of hazard estimates and unadjusted 95% confidence intervals for
high gene expression relative to low gene expression demonstrates differences in survival based upon the expression of the target genes. Gene
targets are marked with identifiers for binarized expression variables showing adjusted P-values <0.05 (false discovery rate (FDR), 0.05) (denoted
by ** or ++) and adjusted P-values <0.1 (FDR, 0.1) (denoted by * or +). Single asterisk indicates a significant finding after adjustment for multiple
comparisons using the G-rho model test (ρ = 1). Single plus sign indicates a significant finding after adjustment for multiple comparisons using
an omnibus test from a Cox model with biomarker and IntClust subtype and their interaction terms. K-W, Kruskal-Wallis test.
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transmembrane/extracellular gene set, we found that
211 (0.21%) of the 10,000 of the random sets showed
40 or more genes to be significantly associated with
the 10 METABRIC groups (null hypothesis simulation
Kruskal-Wallis P = 0.021). For the PAM50 subtypes,
637 (0.637%) of 10,000 of the random sets of 47 genes
showed 39 or more genes with an adjusted P-value <0.05
(null hypothesis simulation Kruskal-Wallis P = 0.064).
Thus, the identified set of 47 genes is unlikely to be simply
a randomly assembled set, suggesting that this gene set is
enriched with regard to association with breast cancer
subtype.
Finally, we asked whether expression differences in
any of the 47 genes exhibit independent disease outcome
associations (overall survival) in the 1,998-patient dataset.
This was tested using two methods of multivariable
analysis to determine if the prognostic significance of the
gene expression was independent of that already carried
by the breast cancer subtype (see the Methods section for
details). The ranked proportional hazards with respect to
overall survival (Figure 9C) for each gene showed a
range of effect sizes. Two gene targets showed significant
differences in survival within IntClust breast cancer subtype
groups as assessed by Kaplan-Meier G-rho-stratified
analysis and by Cox proportional hazards analysis,
after adjustment for multiple comparisons using the
method of Benjamini and Hochberg [26]. Elevated CD79A
expression showed improved survival for IntClusts 8 and
10 (Additional file 14: Figure S11). Elevated SERPINH1
expression showed poorer survival for IntClusts 6, 9 and
10. An additional two gene targets showed significant dif-
ferences as assessed by the Kaplan-Meier G-rho-stratified
analysis, after adjustment for multiple comparisons.
Elevated KCNJ5 expression showed poorer survival for
IntClusts 4 and 8. Elevated TMEM14C expression showed
improved survival for IntClust 4.
Discussion
The extracellular factors and transmembrane signals
that regulate mammary epithelial growth and differentiationremain poorly understood. In part, this is due to a lack of
methods for systematic, genome-wide, genetic and
functional interrogation of genes in relation to mammary
epithelial growth and differentiation. Although genome-
wide functional screens using RNAi methods have proven
successful in many similar instances (for example, see
[58,59]), these have mostly been undertaken with trans-
formed, somatically mutated epithelial cell types, where
key extracellular interactions that modulate growth cannot
be recapitulated. Important features of the endogenous
milieu, such as growth stimulation by fibroblast stroma
have been undersampled as a consequence. To overcome
this, we isolated and characterized a cloned, diploid, non-
transformed mammary epithelial cell line, 184-hTERT-L9,
which retains both fibroblast growth dependence and the
capacity to differentiate in three-dimensional growth con-
ditions. We used this cell line in a genome-wide RNAi
screen to identify, in a systematic manner, genes required
for mammary progenitor cell growth and differentiation.
The 184-hTERT-L9 clone described here is derived from
primary mammary epithelium immortalized by hTERT
transfection after limited initial passages. The clonal line
retains important properties, such as fibroblast-dependent
growth and the ability to differentiate in three-dimensional
cultures, and is diploid and nontransformed.
Fibroblasts are known to possess an instructive role
in regulating mammary epithelial cells in normal develop-
ment and oncogenesis [6,60,61]. More specifically, the
in vitro growth of bipotent progenitor cells is reliant upon
the presence of fibroblasts as feeder cells. The 184-hTERT-L9
cells mimic the growth of bipotent progenitor cells when
plated with increasing densities of irradiated NIH 3T3 feeder
cells in a well-defined colony-forming assay. This is not
observed in epithelial cell lines with genomic aberrations
and/or additional adaptation events, such as MCF10A cells
(Figure 2) and transformed epithelial cells derived from
malignancies. Thus, 184-hTERT-L9 cells provided a
genomically characterized model system, also amenable
to RNAi transfection and image-based, high-content
screening, whereby we could replicate in vitro the fibroblast-
dependent growth environment of mammary progenitor
Table 1 Relative effects of the 47 target genes in two-dimensional and three-dimensional culturesa
Gene
name
RefSeq ID Relative rank, primary
screen (N = 47)
Median relative rank,
secondary screen (N = 47)
Relative rank,
three-dimensional






ACE2 NM_021804 22 30 11 5.169 Lethal
ADCY4 NM_139427 44 17 44 0.878 Lethal
BDKRB2 NM_000623 28 44 31 2.484 Growth postselection
BST1 NM_004334 7 6 14 4.406 Lethal
CD79A NM_001783 13 16 33 2.366 Growth postselection
COL9A3 NM_001853 16 4 22 3.489 Lethal
CTNNA1 NM_001903 37 29 18 4.047 Lethal
EFNAA NM_005227 38 37 5 7.338 Growth postselection
FIT1 NM_203402 4 22 No data No data Growth postselection
FL_J30634 NM_153014 15 30 17 4.055 Growth postselection
FLOT2 NM_004475 23 31 41 1.618 Lethal
FZD2 NM_001466 6 25 19 3.7126 Lethal
GPR182 NM_007264 9 20 32 2.483 Growth postselection
GPR39 NM_001508 10 22 26 3.159 Growth postselection
GPR80 NM_080818 32 14 27 3.137 Lethal
HSD17B2 NM_002153 27 38 2 27.328 Lethal
KCNJ5 NM_000890 3 35 42 1.494 Growth postselection
KTELC1 NM_020231 8 17 No data No data Growth postselection
LGALS1 NM_002305 36 7 16 4.120 Growth postselection
LPAR3 NM_012152 1 5 20 3.530 Growth postselection
LTBP3 NM_021070 39 28 9 5.291 Growth postselection
MMP24 NM_00690 40 5 8 5.447 Growth postselection
MMP28 NM_024302 18 25 37 2.075 Lethal
NKAIN4 NM_152864 20 9 21 3.505 Lethal
NPTX1 NM_002522 45 18 6 7.082 Lethal
NTN1 NM_004822 47 22 10 5.175 Growth postselection
NTN2L NM_006181 5 30 13 4.691 Growth postselection
OPRS1 NM_005866 29 26 24 3.243 Lethal
PARD3 NM_019619 30 31 15 4.221 Lethal
PCDHB13 NM_018933 46 27 43 1.214 Growth postselection
PDCD1 NM_00518 21 36 28 2.997 Growth postselection
PLA2G2F NM_022819 19 22 38 2.028 Lethal
PLUNC NM_016583 31 30 23 3.280 Growth postselection
PROCR NM_006404 35 36 1 31.637 Growth postselection
RHCE NM_020485 42 31 35 2.209 Lethal
RIPK2 NM_003821 41 23 No data No data Lethal
ROBO3 NM_022370 11 35 39 2.012 Growth postselection
SAA1 NM_000331 14 21 12 5.167 Lethal
SCARB2 NM_005506 34 9 34 2.317 Lethal
SEMA3C NM_006379 12 25 40 1.936 Growth postselection
SERPINH1 NM_001235 26 32 25 3.187 Lethal
SLC6A4 NM_001045 17 29 36 2.142 Growth postselection
SNN NM_003498 24 30 3 11.523 Lethal
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Table 1 Relative effects of the 47 target genes in two-dimensional and three-dimensional culturesa (Continued)
TMEM14C NM_016462 33 32 7 5.884 Lethal
TMEM9B NM_020644 43 23 30 2.556 Lethal
TUFT1 NM_020127 25 20 4 7.399 Lethal
/47 /47 /44
aThe relative rank of target genes in the primary small interfering RNA (siRNA) screen, the median relative rank in the secondary siRNA screen and the relative
rank in the three-dimensional acinar growth assay are displayed. The fold decrease in structure formation for each target gene is displayed for each siRNA relative
to the control condition. The effect of infection with an independent lentiviral short-hairpin (shRNA) clone against each target gene is shown after selection with
puromycin (resistance marker within lentiviral construct) as a binary effect (lethal or growth postselection).
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in regulating mammary epithelial and progenitor cell growth.
Among the 21,121 siRNA pools tested in the primary
screen, 2,337 demonstrated statistically significant abro-
gation of growth to less than 25% of the control condi-
tion. This was a stringent selection criterion, given that
knockdown of receptors for two of the four defined
medium components (insulin, EGF, transferrin and
isoproterenol) did not achieve this level of growth inhib-
ition. Surprisingly, GPCR and associated signalling
proteins were also found amongst this list, suggesting
an underappreciated role of this class of receptors
within mammary gland biology.
To identify novel external regulators and signal transduc-
ers, we focused our in-depth analysis on cell surface and
secreted genes. After rescreening including an independ-
ently cloned sister cell to assess reproducibility, and after
qPCR assessment for on-target siRNA activity, we identified
47 transmembrane genes for follow-up examination by
deconvolution and by assaying growth using independently
targeted shRNA constructs (summarized in Table 1).
Moreover, we quantified the relative influence of prolifera-
tion and apoptosis for each gene, which indicated a
general inverse correlation between these two functions.
Although these 47 genes have diverse functions, they
are strikingly enriched for both GPCRs (LPAR3, FZD2,
ADMR, BDKRB2, GPR39, GPR80 and GPR182) (noted
in the primary screen) and axonal guidance molecules
(SEMA3C, PLXNA2, ROBO3, EFNA4, NTN1 and NTN2L).
For many of these genes, we provide the first description of
a role in growth regulation or mammary biology.
To better understand the roles of these genes in growth
and differentiation (reviewed in [62]), we assessed the
requirement of the 47 validated target genes for growth in
three-dimensional culture. The silencing of all but four of
the genes (ADCY4, PCDHB13, KCNJ5 and FLOT2)
decreased three-dimensional acinar formation to a level
comparable to that seen with PLK1 silencing (which is
essential for mitosis). Intriguingly, we have shown that
LPAR3 is required for two-dimensional and three-
dimensional mammary growth. Given the established
importance of LPAR1, LPAR2 and LPAR3 in mammary
tumourigenesis, we wanted to confirm that LPAR1
and LPAR2 are indeed irrelevant for growth of normalepithelium (as determined in the primary genetic
screen). Colony formation in two-dimensional assays
and three-dimensional acinar formation within Matrigel
still occur upon silencing of LPAR1 and LPAR2, suggesting
that they are not required for the growth of normal,
nontransformed epithelial cells. LPAR3 has a greater
binding affinity for 2-acyl-LPA with unsaturated fatty
acids, whereas LPAR1 and LPAR2 are more responsive to
saturated acyl chains [63]. With responsiveness to a
similar ligand, it is possible that compensatory redundancy
exists between LPAR1 and LPAR2.
Some of the genes identified as regulating growth
in two dimensions also affected differentiation when
epithelial cells were grown in three-dimensions, with
SNN, HSD17B2 and PROCR showing greater than tenfold
reduction in acinar formation. The requirement for
long-term cultures (21 days) and the lethality of the
shRNAs for SNN and HSD17B2 precluded analysis of
these two genes; however, reduction of PROCR in
long-term cultures was associated with absence of
lumen formation and disorganized epithelial growth.
We quantified the relative effects on epithelial
organization and lumen formation and observed that
disordered differentiation was also present for two axonal
pathfinding associated genes, EFNA4 and NTN1, and
for LGALS1 (Additional file 1: Figure S7, Figure 8),
with differential effects on polarization and epithelial
organization. PROCR has been implicated as a receptor
for protease-cleaved substrates in breast cancer migration
[64] and as a marker of colony-forming cells in malignant
cell lines [65]. Here we show for the first time, to our
knowledge, a role in growth and differentiation of primary
breast epithelium. Loss of NTN1 causes disorganization in
the terminal end buds, an effect that is proposed to occur
through the loss of cellular adhesions [66]. It has also been
shown that implantation of NTN1-secreting pellets into
mammary glands during pregnancy increases the number
of alveolar structures that develop [67]. In the present
study, we show a role for NTN1 in both luminal and
bipotent progenitor cell growth in that it was required for
colony formation in our in vitro assays.
Finally, genes required for growth and differentiation
are often implicated in tumourigenesis. In this study, we
identified a subset of genes that have not previously been
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We sought to determine if expression of these genes
correlated with any of the breast cancer subtypes.
Significant, nonrandom differences in expression distribu-
tion across the 10 METABRIC datasets was seen for 40 of
the 47 genes, with several genes (for example, RIPK2,
EFNA4 and TMEM9B) differentially expressed in breast
cancer subtypes with high proliferation. Furthermore, we
were able to demonstrate independent prognostic signifi-
cance for CD79A (with elevated expression improving
survival in two of the ten METABRIC subtypes) and
SERPINH1 (with elevated expression decreasing survival in
three of the ten METABRIC subtypes). The possible roles
of these genes in the tumour subtypes studied requires
future functional studies in representative models; however,
it is notable that all of the genes studied here are accessible
by virtue of solubility or membrane location, making them
a practical choice for intervention.
Conclusions
This work shows for the first time, to our knowledge,
the diversity of transmembrane signals and/or proteins
required for the growth of nontransformed mammary
epithelial cells in the physiological state where extracellular
signals from fibroblasts are required. In doing so, we
demonstrate the functional requirement of several
transmembrane and extracellular proteins in normal
mammary growth in multiple well-accepted models of
in vitro mammary physiology. Taken further, these
proteins were differentially associated with breast cancer
subtypes, which were examined in 1,998 patients,
indicating that these proteins may be associated with the
biology of breast cancer subtypes. This is of particular
note, as the location of these proteins makes them
amenable to therapeutic intervention.
Additional files
Additional file 1: Figure S7. Target gene expression is necessary for
normal acinar formation in three-dimensional culture. 184-hTERT-L9 cell
lines with stable integration of pGIPZ shRNA lentiviral constructs against
EFNA4, LGALS1, NTN1, PROCR or a nontargeting control were seeded into
three-dimensional Matrigel culture and fixed after 21 days of growth.
Staining was performed with Alexa Fluor 546–conjugated phalloidin and
DRAQ5 nuclear stain prior to imaging on a Nikon confocal laser scanning
microscope. For E-cadherin, the percentage of structures that were hol-
low versus filled was quantified for each condition, with LGALS1 showing
a significant increase in the percentage of filled structures relative to the
control. For CD49f (marker of basal polarity), the percentage of structures
that were polarized versus nonpolarized was quantified, with PROCR
showing a complete reversal of polarization relative to the control and
other siRNAs. For GM130 (a marker of apical polarity), the percentage of
structures that were polarized versus nonpolarized was quantified, with
all of the siRNAs tested showing a decrease in polarized structures rela-
tive to the nontargeting siRNA control. Examples of the patterns scored
in each case are shown in the upper panel series below the table (white
indicates higher fluorescence intensity). The middle panel represents the
same images with the greyscale inverted to better reveal the antibodypattern (dark indicates higher fluorescence intensity). The presence of
apoptotic cells in the siNTN1 structures is shown in the bottom panel
(dark reddish-brown indicates caspase by immunohistochemistry).
Additional file 2: Figure S8. Epithelial organization is disrupted in
three-dimensional culture with silencing of target genes. (A) 184-hTERT-L9
cell lines with stable integration of pGIPZ shRNA lentiviral constructs against
EFNA4, LGALS1, NTN1, PROCR or a nontargeting control were seeded into
three-dimensional Matrigel culture and fixed after 21 days of growth. Stain-
ing was performed with Alexa Fluor 546–conjugated phalloidin and DRAQ5
nuclear stain prior to imaging on a Nikon confocal laser scanning micro-
scope. Magnified views of representative structures for each condition are
presented for CD49f, E-cadherin and GM130 staining. (B) The same
images shown in (A) are depicted with greyscale inverted for visual clarity.
Additional file 3: Figure S1. 184-hTERT-L9 cells are a cytogenetically
normal cloned human mammary epithelial cell line. (A) Southern blots
of HindIII- and BglII-digested DNA with a cDNA probe targeting the
neomycin resistance gene present on a lentiviral construct used to
immortalize the cells showing one band per digestion, suggesting a
single integration site and a single population of cells after cloning in three
representative cell lines (184-hTERT-L9, 184-hTERT-L5 and 184-hTERT-L2). (B)
Immunohistochemistry of formalin-fixed, paraffin-embedded 184-hTERT-L9
cell blocks shows ubiquitous expression of keratin 5/6, epidermal growth
factor receptor, the epithelial cell marker E-cadherin and wild-type p53.
There is no detectable expression of oestrogen receptor α (ERα) or human
epidermal growth factor receptor 2 (HER2). (C) Western blots of clonal
184-hTERT-L9, 184-hTERT-L5, 184-hTERT-L9 and primary unsorted mammary
epithelial cells (HMECs) with antibodies raised against β-actin, keratin 18,
keratin 5, p63 and p16. (D) Array-based comparative genomic hybridization
was performed using the Affymetrix GeneChip SNP 6.0 array (Affymetrix,
Santa Clara, CA, USA). Log2 ratios of signal intensity for 184-hTERT cell lines
compared to normal human female reference DNA are plotted in relation
to chromosomal position.
Additional file 4: Table S1. Contrasting properties of the 184-hTERT-L9
[20] and MCF10A [17,68,69] cell lines.
Additional file 5: Figure S3. Irradiated fibroblasts are not susceptible to
siRNA-mediated RNA interference. (A) Irradiated murine NIH 3T3 cells do
not efficiently mediate RNAi with a universal cell-lethal siRNA. Irradiated
NIH 3T3 cells at a density of 30,000 cells/cm2 were transfected with
increasing concentrations of transfection reagent. After 48 hours, live-dead
discrimination was performed (calcein AM/ethidium homodimer 1) and
enumerated using the IN Cell Analyzer and IN Cell Developer software
(GE Healthcare Bio-Sciences). The percentage of viable cells was determined
in comparison to nontransfected control wells. Error bars represent standard
deviation (n = 2). (B) Irradiated fibroblasts do not show protein target
knockdown. Irradiated NIH 3T3 cells at a density of 10,000 cells/cm2 were
transfected with 50 nM pooled siRNAs targeting β-actin complexed with
increasing transfection reagent concentrations. After 96 hours, β-actin
(green) and lamin C (red) levels were detected using the LI-COR Odyssey
imaging system (LI-COR Biotechnology, Lincoln, NE, USA). (C) Irradiated
fibroblasts do not show protein target knockdown. Irradiated IMR-90 human
fibroblasts at a density of 10,000 cells/cm2 were transfected with 50 nM
pooled siRNAs targeting human GAPDH, with transfection reagent alone
(Lipofectamine 2000) and with a nontargeting siRNA (siCon3) as controls.
After 72 hours, Western blotting was performed with both GAPDH and then
β-actin (control). (D) The cell killing abilities of siPLK1 and siTOX were
compared in irradiated and nonirradiated NIH 3T3 cells. Cell number was
assessed (confluence over time) on the IncuCyte ZOOM live cell microscope
for irradiated and nonirradiated NIH 3T3 cells with increasing concentrations
of siTOX and mouse siPLK1. Nontransfected cells (Lipofectamine 2000) were
included as the control. Cell number was not above starting and/or control
conditions for the irradiated fibroblasts, as expected, given their arrested
state. Application of siTOX to the irradiated cells had no significant effect on
irradiated cell viability (no difference from controls; Dunnett-adjusted
P > 0.05). In contrast, in the nonirradiated cells, both siPLK1 and siTOX result
in cell killing compared to the control (Dunnett-adjusted P < 0.02).
Additional file 6: Figure S2. Optimization of genome-wide siRNA
screening parameters and external validation of results. (A) Total nuclear
count accurately reflects the 184-hTERT count in the co-culture screening
assay. Comparison of total nuclear count and GFP-positive count in
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that the total count can be used as a surrogate for the GFP-positive
count. Three thousand irradiated NIH 3T3 cells were plated with four
hundred 184-hTERT-GFP cells in 96-well plates prior to transfection with
0.3 μl of Lipofectamine 2000 reagent and 30 nM of siRNA per well.
Twenty-one fields of view were acquired after 5 days of growth using a
10× lens objective on the IN Cell Analyzer. The GFP-negative count was
obtained by subtracting the GFP-positive count (green diamond) from
the total nuclear count (red square) and represents the number of irradiated
fibroblasts present in each well (blue triangle). (B) Deconvolution of siRNA
pools and RNA interference with lentiviral shRNA constructs externally
validates different subsets of genes. Genes listed in blue and purple within
the Venn diagram represent genes with which 184-hTERT cells infected with
an independently designed lentiviral shRNA construct were unable to grow
in culture after puromycin was applied to the cells as a means of selection
for stable integration of the lentiviral construct. Genes listed in red and
purple within the Venn diagram represent genes with which knockdown
with three or four of the individual siRNAs comprising the original siRNA
pool led to a statistically significant decrease in cell growth (adjusted
P < 0.05 by Benjamini-Hochberg multiple-comparisons method).
Additional file 7: Table S2. (A) Ranked growth effect of the 21,121
genes evaluated in the primary siRNA screen. (B) Ranked growth effect of
the 388 extracellular and plasma membrane genes evaluated in the
secondary siRNA screen. (C) Relative effects of the 47 target genes in
two-dimensional and three-dimensional cultures, as well as their status in
the METABRIC and COSMIC databases. (D) Relative transcript levels after
lentiviral shRNA silencing in 184-hTERT-L9 cells. (E) RT-qPCR primers and
corresponding Roche Universal ProbeLibrary (Roche Applied Science,
Penzberg, Germany) probe number utilized for RT-qPCR. (F) Functional
enrichment scores for 47 target genes. Functional annotation clustering
was performed on the 47 genes required for 184-hTERT-L9 cell growth
using the Gene Functional Classification tool in the DAVID Bioinformatics
Database [39]. The data used to derive the annotation clustering heat
maps in Additional file 10: Figure S6 are listed.
Additional file 8: Figure S4. Relative contribution of proliferation and
apoptosis of target genes in two-dimensional culture. (A) Cell proliferation
as measured by AUC over time by high-content imaging is positively
correlated with the fraction of cells in S-phase, determined by EdU
incorporation. EdU incorporation was performed in 24-well plates containing
184-hTERT-L9 cells stably transfected with NucLight Red. Cells were
transfected with 30 nM siRNA 24 hours after plating and labelled with EdU
68 hours posttransfection. Labelling was detected with the Click-iT EdU Alexa
Fluor 488 Flow Cytometry Assay Kit and analysed by flow cytometry. (B) Cell
proliferation (AUC over time, median value in red) and relative apoptosis
(caspase-3/7 activity, median value in green) in the target genes by
rank-ordered effects on proliferation display an inverse correlation. 184-hTERT
cells stably infected with NucLight Red were plated without feeder cells and
transfected 24 hours later with 30 nM of siRNA to the respective target genes.
CellPlayer Caspase-3/7 reagent was used to mark apoptotic cells after an
additional 24 hours. Proliferation was measured every 4 hours for 84 hours,
with respective AUCs for serial measurements calculated for each condition
for red (proliferating) or dual-labelled (apoptotic) cells.
Additional file 9: Figure S5 Relative contributions of proliferation
and apoptosis of target genes in two-dimensional culture is un-
changed by the presence of feeder cells. Cell proliferation (AUC over
time, median value in red) and relative apoptosis (caspase-3/7 activity,
median value in green) in the target genes by rank-ordered effects on
proliferation display an inverse correlation. 184-hTERT cells stably infected
with NucLight Red were plated with irradiated NIH 3T3 feeder cells and
transfected 24 hours later with 30 nM of siRNA to the respective target
genes. CellPlayer Caspase-3/7 reagent was used to mark apoptotic cells
after an additional 24 hours. Proliferation was measured every 4 hours for
84 hours, with respective AUCs for serial measurements calculated for
each condition for red (proliferating) or dual labelled (apoptotic) cells.
Genes with the greatest effect on growth affect both proliferation and
apoptosis. (PNG 148 kb)
Additional file 10: Figure S6. Genes identified through screening and
functionally related. (A) Functional annotation clustering was performed
on the 47 genes required for 184-hTERT-L9 cell growth using the GeneFunctional Classification tool in the DAVID Bioinformatics Database [39].
The cluster of genes involved in axon guidance are highlighted by red
stars on the Kyoto Encyclopedia of Genes and Genomes (KEGG) human
axon guidance pathway [40,41]. (B) Functional annotation clustering was
performed on the 47 genes required for 184-hTERT-L9 cell growth using
the Gene Functional Classification tool in the DAVID Bioinformatics
Database [39]. Enrichment clusters are depicted for genes with their
corresponding associated Gene Ontology biological process terms. Posi-
tive gene term associations are represented in green, and currently unre-
ported gene term associations are represented in black.
Additional file 11: Table S3. Target genes are not differentially
expressed in freshly sorted RNA-seq libraries of enriched luminal versus
enriched myoepithelial cells taken from human reduction mammoplasty
samples. Data from three independent paired libraries of mammary
luminal and myoepithelium for each target gene are shown along with
luminal:basal expression ratios and the P-values calculated with the
Wilcoxon and Student’s t tests and the Holm-Bonferroni adjustment.
No statistically significant differences (Holm-Bonferroni-adjusted
P-values >0.05) were observed.
Additional file 12: Figure S9. Beanplots depicting target gene
expression in the ten biological primary breast cancer subgroups. The
individual observations are shown as small horizontal lines in a
one-dimensional scatterplot with the estimated density of the distributions
shown in colour and the average indicated by the long horizontal line.
Additional file 13: Figure S10. Beanplots depicting target gene
expression in the PAM50 breast cancer subgroups. The individual
observations are shown as small horizontal lines in a one-dimensional
scatterplot with the estimated density of the distributions shown in
colour and the average indicated by the long horizontal line.
Additional file 14: Figure S11. Independent disease outcome
associations are present with select target genes. Individual genes shown
in Figure 9C are depicted with significant survival differences with low
(green) versus high (red) gene expression for both integrative cluster
(IntClust) breast cancer subtype groups and PAM50 subtypes. Associations
were assessed by Kaplan-Meier G-rho-stratified analysis and by Cox
proportional hazards analysis, after adjustment for multiple comparisons
using the method of Benjamini and Hochberg [26]. CD79A expression
shows improved survival for IntClusts 8 and 10 and HER2. KCNJ5 expression
shows poorer survival for IntClusts 4 and 8. SERPINH1 expression shows
poorer survival for IntClusts 6, 9 and 10. TMEM14C expression shows
improved survival for IntClust 4 and luminal B.
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